Abstract—The aim of this study was to compare neurochemical changes induced by the dipeptide analogue of piracetam, the ethyl ester of N-phenylacetyl-L-prolylglycine (noopept), in the brain structures of BALB/c and C57BL/6 mice with different genetically determined responses to emotional stress. It was found using the HPLC technique that noopept at doses of 0.5 and 2.5 mg/kg after acute administration reduced the content of dopamine (DA) and its metabolite homovanillic acid (HVA) in the frontal cortex of both strains of mice. In “highly anxious” BALB/c mice, noopept increased the intracellular DA turnover (DOPAC/DA) and the total DA turnover (HVA/DA) in the frontal cortex, increased the level of noradrenaline and the metabolic rate of DA and serotonin in the hypothalamus, and increased the total DA turnover in the striatum. Noopept had no effect on the content of neurotransmitter amino acids in the brain structures of mice of both strains.
Similar content being viewed by others
REFERENCES
Ostrovskaya, R.U., Gudasheva, T.A., Voronina, T.A., and Seredenin, S.B., Eksperimental’naya i klinicheskaya farmakologiya, 2002, vol. 65, no. 5, pp. 66–72.
Bochkarev, V.K., Teleshova, E.S., Syunyakov, S.A., Davydova, D.V., and Neznamov, G.G., Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova, 2008, vol. 108, no. 11, pp. 47–54.
Neznamov, G.G. and Teleshova, E.S., Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova, 2008, vol. 108, no. 3, pp. 33–42.
Ostrovskaya, R.U. and Gudasheva, T.A., Eksperimental’naya i Klinicheskaya Farmakologiya, 2021, vol. 84, no. 2, pp. 41–52.
Ostrovskaya, R.U., Seredenin, S.B., Voronina, T.A., Molodavkin, G.M., and Gudasheva, T.A., in Animal Models in Biological Psychiatry, Kalueff, A.V, Ed., USA: Nova Science Publ., 2006, pp. 165-182 .
Bel’nik, A.P., Ostrovskaya, R.U., and Poletaeva, I.I., Zhurnal Vysshei nervnoi deyatel’nosti im. I. P. Pavlova, 2007, vol. 57, no. 5, pp. 613–617.
Bel’nik, A.P., Ostrovskaya, R.U., and Poletaeva, I.I., Zhurnal Vysshei Nervnoi Deyatel’nosti im. I.P. Pavlova, 2007, vol. 57, no. 6, pp. 717–724.
Kovalev, G.I., Kondrakhin, E.A., Salimov, R.M., and Neznamov, G.G., Eksperimental’naya i Klinicheskaya Farmakologiya, 2014, vol. 77, no. 12, pp. 49–55.
Vasil’eva, E.V., Kondrakhin, E.A., Abdullina, A.A., Salimov, R.M., and Kovalev, G.I., Neurochem. J., 2020, vol. 14, no. 3, pp. 268–278.
Nadorova, A.V., Kolik, L.G., Klodt, P.M., Narkevich, V.B., Naplekova, P.L., Kozlovskaya, M.M., Kudrin, V.S., and Seredenin, S.B., Neurochem. J., 2014, vol. 8, no. 2, pp. 115–120.
Kolik, L.G., Nadorova, A.V., Kon’kov, V.G., Narkevich, V.B., and Kudrin, V.S., Neurochem. J., 2021, vol. 15, no. 2, pp. 196–202.
Narkevich, V.B., Kudrin, V.S., Klodt, P.M., Pokrovskii, A.A., Kozlovskaya, M.M., Maiskii, A.I., and Raevskii, K.S., Eksperimental’naya i Klinicheskaya Farmakologiya, 2008, vol. 71, no. 5, pp. 28–31.
Messiha, F., Neurotoxicol., 1991, vol. 12, no. 1, pp. 47–54.
Messiha, F., Toxicol. Letters, 1991, vol. 58, pp. 77–84.
Anderzhanova, E.A., Bachli, H., Buneeva, O.A., Narkevich, V.B., Medvedev, A.E., Thoeringer, C.K., Wotjak, C.T., and Kudrin, V.S., Eur. J. Pharmacol., 2013, vol. 708, pp. 95–104.
Siesser, W.B., Zhang, X., Jacobsen, J.P.R., Sotnikova, T.D., Gainetdinov, R.R., and Caron, M.G., Neurosci. Let., 2010, vol. 481, no. 1, pp. 6–11.
Bach, H., Arango, V., Huang, Y.Y., Leong, S., Mann, J.J., and Underwood, M.D., J. Neurochem., 2011, vol. 118, no. 6, pp. 1067–1074.
Kovalev, G.I., Kondrakhin, E.A., Salimov, R.M., and Neznamov, G.G., Eksperimental’naya i Klinicheskaya Farmakologiya, 2013, vol. 76, no. 9, pp. 3–10.
Povarov, I.S., Kondratenko, R.V., Derevyagin, V.I., Ostrovskaya, R.U., and Skrebitskii, V.G., Byulleten’ Eksperimental’noi Biologii i Meditsiny, 2014, vol. 158, no. 9, pp. 336–338.
Ostrovskaya, R.U., Gudasheva, T.A., Tsaplina, A.P., Vahitova J.V., Salimgareeva M.H., Jamidanov R.S., and Seredenin S.B., Byulleten’ Eksperimental’noi Biologii i Meditsiny, 2008, vol. 146, no. 9, pp. 310–313.
Vorobyov, V., Kaptsov, V., Kovalev, G., and Sengpiel, F., Brain Res. Bul., 2011, vol. T. 85, nos. 3–4, pp. 123–132.
Us, K.S., Klodt, P.M., Kudrin, V.S., Sapronova, A.Ya., Ostrovskaya, R.U., Ugryumov, M.V., Rayevsky, K.S., Neurochem. J., 2007, vol. 1, pp. 138–142.
Kolesnikov, A.V., Shchul’kin, A.V., Barenina, O.I., Yakusheva, E.N., Kudrin, V.S., Ostrovskaya, R.U., Uzbekov, M.G., and Shishkin, M.M., Neurochem. J., 2019, vol. 13, pp. 62–67.
Funding
The work was supported by the Ministry of Science and Higher Education of the Russian Federation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare that they have no conflicts of interest.
Ethical approval. The study was performed in accordance with the Directive of the Council of the European Community 2010/63/EEC, the decision of the Council of the Eurasian Economic Commission from November 3, 2016, no. 81 “On approval of the Rules of good laboratory practice in the Eurasian Economic Union in the field of circulation of medicines” and the order of the Ministry of Health of Russia no. 199 dated April 1, 2016 “On approval of the rules of good laboratory practice”. The animals were kept in accordance with SP 2.2.1.3218-14 “Sanitary and epidemiological requirements for the arrangement, equipment and maintenance of experimental biological clinics (vivariums)" dated August 29, 2014, No. 51.
Additional information
V. G. Kon’kov is a corresponding author: 125315 Russia, Moscow, Baltiiskaya ul., 8, e-mail: asbest321@gmail.com.
Rights and permissions
About this article
Cite this article
Kon’kov, V.G., Kudrin, V.S., Narkevich, V.B. et al. The Effect of Noopept on the Content of Monoamines and Their Metabolites and Neurotransmitter Amino Acids in the Brain Structures of BALB/c and C57BL/6 Mice: A Comparative Study. Neurochem. J. 16, 161–167 (2022). https://doi.org/10.1134/S181971242202009X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S181971242202009X